The previous page is sending you to http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/make-in-india-can-india-be-a-hub-for-the-200-billion-worth-biosimilars-opportunity/articleshow/51032054.cms.

 If you do not want to visit that page, you can return to the previous page.